麻豆原创

Search

Did you mean
financial regulations
Your search for "Financial Regulation" gave back 114 results.

In Situ Hybridization: 麻豆原创 Shares, Strategies, and Forecasts, Worldwide, 2018 to 2024

Worldwide markets are poised to achieve continuing growth as In Situ Hybridization is used in diagnostic situations to analyze single cells inside...
颁补迟补濒辞驳:听
Pharma & Healthcare
WinterGreen Research
Global
March 2018
Price: USD 4,300.00

2014 Sales of Recombinant Therapeutic Antibodies & Proteins

This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic...
颁补迟补濒辞驳:听
Pharma & Healthcare
La Merie Publishing
Global
March 2015
Price: USD 140.00

2013 Sales of Recombinant Therapeutic Antibodies & Proteins

2013 Sales of Recombinant Therapeutic Antibodies & Proteins This Competitive Intelligence report prepared by La Merie Business Intelligence...
颁补迟补濒辞驳:听
Pharma & Healthcare
La Merie Publishing
Global
March 2014
Price: USD 68.00

Competitor Analysis: Inhibitors of the bromodomain and extra-terminal domain (BET) family

The Competitive Intelligence Report Inhibitors of the bromodomain and extra-terminal domain (BET) family as of January 201 provides a competitor...
颁补迟补濒辞驳:听
Pharma & Healthcare
La Merie Publishing
Global
January 2016
Price: USD 225.00

Competitor Analysis: Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors

The present Competitive Intelligence Report about Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors provides a competitor...
颁补迟补濒辞驳:听
Pharma & Healthcare
La Merie Publishing
Global
February 2014
Price: USD 413.00

Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors

CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors The present Competitive Intelligence Report about CD20 Antibodies - Rituximab...
颁补迟补濒辞驳:听
Pharma & Healthcare
La Merie Publishing
Global
February 2014
Price: USD 401.00

Immune Checkpoint Therapeutics - Hot Targets & Pipeline Analysis

鈥� IMMUNE CHECKPOINT THERAPEUTICS 鈥� HOT TARGETS & PIPELINE ANALYSIS 鈥� gives comprehensive insights on the various Immune Checkpoint modulators...
颁补迟补濒辞驳:听
Pharma & Healthcare
IQ4I
Global
April 2016
Price: USD 4,500.00

Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis 鈥� a 2017 Update

Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis 鈥� a 2017 Update The Competitive...
颁补迟补濒辞驳:听
Pharma & Healthcare
La Merie Publishing
Global
November 2017
Price: USD 525.00

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014

Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
颁补迟补濒辞驳:听
Pharma & Healthcare
La Merie Publishing
Global
March 2014
Price: USD 1,514.00

Contact Us for Custom 麻豆原创 Research Solutions

听

Custom 麻豆原创 Research Reports

Clients Who Trust Us

麻豆原创 Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected